Literature DB >> 9987735

Polycystic ovary syndrome. Insulin resistance and ovulatory responses to clomiphene citrate.

H Murakawa1, I Hasegawa, T Kurabayashi, K Tanaka.   

Abstract

OBJECTIVE: To evaluate insulin secretion detected on oral glucose tolerance testing in relation to clomiphene citrate (CC) responses in women with polycystic ovary syndrome (PCOS). STUDY
DESIGN: A total of 37 PCOS women were enrolled. Plasma baseline levels of gonadotropins, sex hormone binding globulin, androstenedione, dehydroepiandrosterone sulfate and testosterone (T) were determined. Insulin and glucose serum concentrations were analyzed in all samples after a 75-g oral glucose tolerance test. A dose of 100 mg/d of CC was given for ovulation induction. Ovulation was detected by ultrasonographic observation in conjunction with a serum progesterone level.
RESULTS: During three consecutive cycles of CC administration, two or more anovulatory cycles were observed in 12 of 37 PCOS women (defined as CC nonresponders). The serum T level and the area under the curve (AUC) of insulin were significantly higher in CC nonresponders. The receiver operating characteristic curve of the AUC of insulin provided the most appropriate cutoff point for the prediction of CC resistance.
CONCLUSION: We found higher androgen secretion and insulin resistance in CC nonresponders. The AUC of insulin was the most reliable method for the prediction of CC resistance associated with insulin resistance.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9987735

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  6 in total

1.  Effects of low-dose metformin in Japanese women with clomiphene-resistant polycystic ovary syndrome.

Authors:  Takumi Kurabayashi; Mina Suzuki; Katsunori Kashima; Junichi Banzai; Kyoko Terabayashi; Kazuyuki Fujita; Kenichi Tanaka
Journal:  Reprod Med Biol       Date:  2004-03-30

2.  Naltrexone effect on pulsatile GnRH therapy for ovulation induction in polycystic ovary syndrome: a pilot prospective study.

Authors:  A M Fulghesu; M Ciampelli; C Belosi; R Apa; M Guido; A Caruso; S Mancuso; A Lanzone
Journal:  J Endocrinol Invest       Date:  2001 Jul-Aug       Impact factor: 4.256

3.  Sensitive and specific markers for insulin resistance, hyperandrogenemia, and inappropriate gonadotrophin secretion in women with polycystic ovary syndrome: a case-control study from Bahrain.

Authors:  Jamal Golbahar; Maha Al-Ayadhi; Negalla Mohan Das; Khalid Gumaa
Journal:  Int J Womens Health       Date:  2012-05-11

4.  Brachial-to-ankle pulse wave velocity as an independent prognostic factor for ovulatory response to clomiphene citrate in women with polycystic ovary syndrome.

Authors:  Toshifumi Takahashi; Hideki Igarashi; Shuichiro Hara; Mitsuyoshi Amita; Koki Matsuo; Ayumi Hasegawa; Hirohisa Kurachi
Journal:  J Ovarian Res       Date:  2014-07-10       Impact factor: 4.234

5.  Body composition: A predictive factor of cycle fecundity.

Authors:  Semra Kayatas; Aysen Boza; Murat Api; Didar Kurt; Mustafa Eroglu; Sevcan Arzu Arınkan
Journal:  Clin Exp Reprod Med       Date:  2014-06-30

6.  Effects of simvastatin pretreatment on clomiphene response in clomiphene - resistant women with polycystic ovary syndrome.

Authors:  Azam Azargoon; Raheb Ghorbani; Zahra Faraji
Journal:  J Family Reprod Health       Date:  2013-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.